Wnt4 action in gonadal development and sex determination

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 1, 2007, Pages 31-43

  Bernard, Pascal ^a   Harley, Vincent R ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Fgf9; Sex determination; Sox9; Wnt signaling; Wnt4

Indexed keywords

BETA CATENIN; GROWTH FACTOR; GROWTH FACTOR WNT4; UNCLASSIFIED DRUG; WNT PROTEIN;

ENZYME ACTIVITY; GONAD; GONAD DEVELOPMENT; HUMAN; HUMAN GENETICS; MOLECULAR BIOLOGY; MUELLERIAN DUCT; NONHUMAN; OOCYTE; OOCYTE DEVELOPMENT; OVARY DEVELOPMENT; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCTION; REVIEW; SEX DETERMINATION; SEX TRANSFORMATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; TESTIS DEVELOPMENT; VASCULARIZATION;

ANIMALS; DISORDERS OF SEX DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MICE; OVARY; PROTO-ONCOGENE PROTEINS; SEX DETERMINATION (GENETICS); SEX DETERMINATION PROCESSES; SEX DIFFERENTIATION; SEX REVERSAL, GONADAL; SIGNAL TRANSDUCTION; WNT PROTEINS;

MAMMALIA;

EID: 33749618706     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.06.007     Document Type: Review

References (96)

1. Akiyama H., Lyons J.P., Mori-Akiyama Y., Yang X., Zhang R., Zhang Z., et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18 9 (2004) 1072-1087
2. Argentaro A., Sim H., Kelly S., Preiss S., Clayton A., Jans D.A., et al. A SOX9 defect of calmodulin-dependent nuclear import in campomelic dysplasia/autosomal sex reversal. J. Biol. Chem. 278 36 (2003) 33839-33847
3. Bardoni B., Zanaria E., Guioli S., Floridia G., Worley K.C., Tonini G., et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat. Genet. 7 4 (1994) 497-501
4. Barrionuevo F., Bagheri-Fam S., Klattig J., Kist R., Taketo M.M., Englert C., et al. Homozygous inactivation of Sox9 causes complete XY sex reversal in mice. Biol. Reprod. 74 1 (2006) 195-201
5. Behringer R.R., Cate R.L., Froelick G.J., Palmiter R.D., and Brinster R.L. Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance. Nature 345 6271 (1990) 167-170
6. Behringer R.R., Finegold M.J., and Cate R.L. Mullerian-inhibiting substance function during mammalian sexual development. Cell 79 3 (1994) 415-425
7. Berta P., Hawkins J.R., Sinclair A.H., Taylor A., Griffiths B.L., Goodfellow P.N., et al. Genetic evidence equating SRY and the testis-determining factor. Nature 348 6300 (1990) 448-450
8. Biason-Lauber A., Konrad D., Navratil F., and Schoenle E.J. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46 XX woman. N. Engl. J. Med. 351 8 (2004) 792-798
9. Birk O.S., Casiano D.E., Wassif C.A., Cogliati T., Zhao L., Zhao Y., et al. The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 403 6772 (2000) 909-913
10. Brembeck F.H., Rosario M., and Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 16 1 (2005) 51-59
11. Brennan J., and Capel B. One tissue, two fates: Molecular genetic events that underlie testis versus ovary development. Nat. Rev. Genet. 5 7 (2004) 509-521
12. Brennan J., Karl J., and Capel B. Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. Dev. Biol. 244 2 (2002) 418-428
13. Brennan J., Tilmann C., and Capel B. Pdgfr-alpha mediates testis cord organization and fetal Leydig cell development in the XY gonad. Genes Dev. 17 6 (2003) 800-810
14. Cadigan K.M., and Nusse R. Wnt signaling: A common theme in animal development. Genes Dev. 11 24 (1997) 3286-3305
15. Cai Y., Lechner M.S., Nihalani D., Prindle M.J., Holzman L.B., and Dressler G.R. Phosphorylation of Pax2 by the c-Jun N-terminal kinase and enhanced Pax2-dependent transcription activation. J. Biol. Chem. 277 2 (2002) 1217-1222
16. Carroll T.J., Park J.S., Hayashi S., Majumdar A., and McMahon A.P. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev. Cell 9 2 (2005) 283-292
17. Chaboissier M.C., Kobayashi A., Vidal V.I., Lutzkendorf S., van de Kant H.J., Wegner M., et al. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 131 9 (2004) 1891-1901
18. Clark A.M., Garland K.K., and Russell L.D. Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules. Biol. Reprod. 63 6 (2000) 1825-1838
19. Colvin J.S., Green R.P., Schmahl J., Capel B., and Ornitz D.M. Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104 6 (2001) 875-889
20. Couse J.F., Hewitt S.C., Bunch D.O., Sar M., Walker V.R., Davis B.J., et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 286 5448 (1999) 2328-2331
21. Cousineau A.J., Higgins J.V., Hackel E., Waterman D.F., Toriello H., Carlile P.A., et al. Cytogenetic recognition of chromosomal duplication [dup(1)(p31.4 leads to p22.1)] and the detection of three different alleles at the PGM1 locus. Ann. Hum. Genet. 45 Pt 4 (1981) 337-340
22. Dailey L., Laplantine E., Priore R., and Basilico C. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J. Cell Biol. 161 6 (2003) 1053-1066
23. Devgan V., Mammucari C., Millar S.E., Brisken C., and Dotto G.P. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 19 12 (2005) 1485-1495
24. Dinapoli L., Batchvarov J., and Capel B. FGF9 promotes survival of germ cells in the fetal testis. Development 133 8 (2006) 1519-1527
25. Du S.J., Purcell S.M., Christian J.L., McGrew L.L., and Moon R.T. Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos. Mol. Cell. Biol. 15 5 (1995) 2625-2634
26. Elejalde B.R., Opitz J.M., de Elejalde M.M., Gilbert E.F., Abellera M., Meisner L., et al. Tandem dup (1p) within the short arm of chromosome 1 in a child with ambiguous genitalia and multiple congenital anomalies. Am. J. Med. Genet. 17 4 (1984) 723-730
27. Foster J.W., Dominguez-Steglich M.A., Guioli S., Kowk G., Weller P.A., Stevanovic M., et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372 6506 (1994) 525-530
28. Golan T., Yaniv A., Bafico A., Liu G., and Gazit A. The human frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. Beta-catenin signaling cascade. J. Biol. Chem. 279 15 (2004) 14879-14888
29. Goodfellow P.N., and Lovell-Badge R. SRY and sex determination in mammals. Ann. Rev. Genet. 27 (1993) 71-92
30. Gottardi C.J., and Gumbiner B.M. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J. Cell Biol. 167 2 (2004) 339-349
31. Gummow B.M., Winnay J.N., and Hammer G.D. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J. Biol. Chem. 278 29 (2003) 26572-26579
32. Heikkila M., Peltoketo H., Leppaluoto J., Ilves M., Vuolteenaho O., and Vainio S. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143 11 (2002) 4358-4365
33. Heikkila M., Prunskaite R., Naillat F., Itaranta P., Vuoristo J., Leppaluoto J., et al. The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. Endocrinology 146 9 (2005) 4016-4023
34. Hollyday M., McMahon J.A., and McMahon A.P. Wnt expression patterns in chick embryo nervous system. Mech. Dev. 52 1 (1995) 9-25
35. Hossain A., and Saunders G.F. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor. J. Biol. Chem. 278 29 (2003) 26511-26516
36. Hou X., Tan Y., Li M., Dey S.K., and Das S.K. Canonical Wnt signaling is critical to estrogen-mediated uterine growth. Mol. Endocrinol. 18 12 (2004) 3035-3049
37. Huang B., Wang S., Ning Y., Lamb A.N., and Bartley J. Autosomal XX sex reversal caused by duplication of SOX9. Am. J. Med. Genet. 87 4 (1999) 349-353
38. Imbeaud S., Belville C., Messika-Zeitoun L., Rey R., di Clemente N., Josso N., et al. A 27 base-pair deletion of the anti-mullerian type II receptor gene is the most common cause of the persistent mullerian duct syndrome. Hum. Mol. Genet. 5 9 (1996) 1269-1277
39. Ishitani T., Ninomiya-Tsuji J., Nagai S., Nishita M., Meneghini M., Barker N., et al. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399 6738 (1999) 798-802
40. Jeays-Ward K., Dandonneau M., and Swain A. Wnt4 is required for proper male as well as female sexual development. Dev. Biol. 276 2 (2004) 431-440
41. Jeays-Ward K., Hoyle C., Brennan J., Dandonneau M., Alldus G., Capel B., et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130 16 (2003) 3663-3670
42. Jordan B.K., Mohammed M., Ching S.T., Delot E., Chen X.N., Dewing P., et al. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am. J. Hum. Genet. 68 5 (2001) 1102-1109
43. Jordan B.K., Shen J.H., Olaso R., Ingraham H.A., and Vilain E. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc. Natl. Acad. Sci. U.S.A. 100 19 (2003) 10866-10871
44. Katayama S., Ashizawa K., Fukuhara T., Hiroyasu M., Tsuzuki Y., Tatemoto H., et al. Differential expression patterns of Wnt and {beta}-catenin/TCF-target genes in the uterus of immature female rats exposed to 17{alpha}-ethynyl estradiol. Toxicol. Sci. 91 2 (2006) 419-430
45. Katoh-Fukui Y., Tsuchiya R., Shiroishi T., Nakahara Y., Hashimoto N., Noguchi K., et al. Male-to-female sex reversal in M33 mutant mice. Nature 393 6686 (1998) 688-692
46. Kent J., Wheatley S.C., Andrews J.E., Sinclair A.H., and Koopman P. A male-specific role for SOX9 in vertebrate sex determination. Development 122 9 (1996) 2813-2822
47. Kim Y., Kobayashi A., Sekido R., DiNapoli L., Brennan J., Chaboissier M.C., et al. Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol. 4 6 (2006) e187
48. Kispert A., Vainio S., and McMahon A.P. Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development 125 21 (1998) 4225-4234
49. Kobayashi A., Shawlot W., Kania A., and Behringer R.R. Requirement of Lim1 for female reproductive tract development. Development 131 3 (2004) 539-549
50. Koubova J., Menke D.B., Zhou Q., Capel B., Griswold M.D., and Page D.C. Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc. Natl. Acad. Sci. U.S.A. 103 8 (2006) 2474-2479
51. Kuhl M., Sheldahl L.C., Malbon C.C., and Moon R.T. Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and frizzled homologs and promotes ventral cell fates in Xenopus. J. Biol. Chem. 275 17 (2000) 12701-12711
52. Kuhl M., Sheldahl L.C., Park M., Miller J.R., and Moon R.T. The Wnt/Ca2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16 7 (2000) 279-283
53. Ludbrook L.M., and Harley V.R. Sex determination: A 'window' of DAX1 activity. Trends Endocrinol. Metabol. 15 3 (2004) 116-121
54. Luo X., Ikeda Y., and Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77 4 (1994) 481-490
55. Lustig B., and Behrens J. The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol. 129 4 (2003) 199-221
56. Lyet L., Louis F., Forest M.G., Josso N., Behringer R.R., and Vigier B. Ontogeny of reproductive abnormalities induced by deregulation of anti-mullerian hormone expression in transgenic mice. Biol. Reprod. 52 2 (1995) 444-454
57. Lyons J.P., Mueller U.W., Ji H., Everett C., Fang X., Hsieh J.C., et al. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds frizzled-6 CRD: Functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp. Cell Res. 298 2 (2004) 369-387
58. Martineau J., Nordqvist K., Tilmann C., Lovell-Badge R., and Capel B. Male-specific cell migration into the developing gonad. Curr. Biol. 7 12 (1997) 958-968
59. Maurus D., Heligon C., Burger-Schwarzler A., Brandli A.W., and Kuhl M. Noncanonical Wnt-4 signaling and EAF2 are required for eye development in Xenopus laevis. EMBO J. 24 6 (2005) 1181-1191
60. Meeks J.J., Weiss J., and Jameson J.L. Dax1 is required for testis determination. Nat. Genet. 34 1 (2003) 32-33
61. Miyamoto N., Yoshida M., Kuratani S., Matsuo I., and Aizawa S. Defects of urogenital development in mice lacking Emx2. Development 124 9 (1997) 1653-1664
62. Mizusaki H., Kawabe K., Mukai T., Ariyoshi E., Kasahara M., Yoshioka H., et al. Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. Mol. Endocrinol. 17 4 (2003) 507-519
63. Mohammed F.M., Farag T.I., Gunawardana S.S., al-Digashim D.D., al-Awadi S.A., al-Othman S.A., et al. Direct duplication of chromosome 1, dir dup(1) (p21.2-p32) in a Bedouin boy with multiple congenital anomalies. Am. J. Med. Genet. 32 3 (1989) 353-355
64. Moon R.T., Campbell R.M., Christian J.L., McGrew L.L., Shih J., and Fraser S. Xwnt-5A: A maternal Wnt that affects morphogenetic movements after overexpression in embryos of Xenopus laevis. Development 119 1 (1993) 97-111
65. Morais da Silva S., Hacker A., Harley V., Goodfellow P., Swain A., and Lovell-Badge R. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat. Genet. 14 1 (1996) 62-68
66. Nef S., Schaad O., Stallings N.R., Cederroth C.R., Pitetti J.L., Schaer G., et al. Gene expression during sex determination reveals a robust female genetic program at the onset of ovarian development. Dev. Biol. 287 2 (2005) 361-377
67. Nef S., Verma-Kurvari S., Merenmies J., Vassalli J.D., Efstratiadis A., Accili D., et al. Testis determination requires insulin receptor family function in mice. Nature 426 6964 (2003) 291-295
68. Nelson W.J., and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303 5663 (2004) 1483-1487
69. Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F., et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271 25 (1996) 15292-15297
70. Osada M., Park H.L., Nagakawa Y., Begum S., Yamashita K., Wu G., et al. A novel response element confers p63- and p73-specific activation of the WNT4 promoter. Biochem. Biophys. Res. Commun. 339 4 (2006) 1120-1128
71. Osafune K., Takasato M., Kispert A., Asashima M., and Nishinakamura R. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development 133 1 (2006) 151-161
72. Parr B.A., and McMahon A.P. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 395 6703 (1998) 707-710
73. Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D., Gosden C., et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346 6280 (1990) 194-197
74. Qin Y., and Bishop C.E. Sox9 is sufficient for functional testis development producing fertile male mice in the absence of Sry. Hum. Mol. Genet. 14 9 (2005) 1221-1229
75. Qin Y., Kong L.K., Poirier C., Truong C., Overbeek P.A., and Bishop C.E. Long-range activation of Sox9 in odd sex (Ods) mice. Hum. Mol. Genet. 13 12 (2004) 1213-1218
76. Schmahl J., and Capel B. Cell proliferation is necessary for the determination of male fate in the gonad. Dev. Biol. 258 2 (2003) 264-276
77. Schmahl J., Kim Y., Colvin J.S., Ornitz D.M., and Capel B. Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development 131 15 (2004) 3627-3636
78. Sekido R., Bar I., Narvaez V., Penny G., and Lovell-Badge R. SOX9 is up-regulated by the transient expression of SRY specifically in Sertoli cell precursors. Dev. Biol. 274 2 (2004) 271-279
79. Sinclair A.H., Berta P., Palmer M.S., Hawkins J.R., Griffiths B.L., Smith M.J., et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346 6281 (1990) 240-244
80. Stark K., Vainio S., Vassileva G., and McMahon A.P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372 6507 (1994) 679-683
81. Swain A., Narvaez V., Burgoyne P., Camerino G., and Lovell-Badge R. Dax1 antagonizes Sry action in mammalian sex determination. Nature 391 6669 (1998) 761-767
82. Tashiro E., Minato Y., Maruki H., Asagiri M., and Imoto M. Regulation of FGF receptor-2 expression by transcription factor E2F-1. Oncogene 22 36 (2003) 5630-5635
83. Terada Y., Tanaka H., Okado T., Shimamura H., Inoshita S., Kuwahara M., et al. Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J. Am. Soc. Nephrol. 14 5 (2003) 1223-1233
84. Tevosian S.G., Albrecht K.H., Crispino J.D., Fujiwara Y., Eicher E.M., and Orkin S.H. Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. Development 129 19 (2002) 4627-4634
85. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., and Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol. 162 5 (2003) 899-908
86. Torban E., Dziarmaga A., Iglesias D., Chu L.L., Vassilieva T., Little M., et al. PAX2 activates Wnt4 expression during mammalian kidney development. J. Biol. Chem. 281 18 (2005) 12705-12712
87. Torres M., Gomez-Pardo E., Dressler G.R., and Gruss P. Pax-2 controls multiple steps of urogenital development. Development 121 12 (1995) 4057-4065
88. Ungar A.R., Kelly G.M., and Moon R.T. Wnt4 affects morphogenesis when misexpressed in the zebrafish embryo. Mech. Dev. 52 2-3 (1995) 153-164
89. Vainio S., Heikkila M., Kispert A., Chin N., and McMahon A.P. Female development in mammals is regulated by Wnt-4 signalling. Nature 397 6718 (1999) 405-409
90. Veeman M.T., Axelrod J.D., and Moon R.T. A second canon functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell 5 3 (2003) 367-377
91. Vidal V.P., Chaboissier M.C., de Rooij D.G., and Schedl A. Sox9 induces testis development in XX transgenic mice. Nat. Genet. 28 3 (2001) 216-217
92. Wagner T., Wirth J., Meyer J., Zabel B., Held M., Zimmer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79 6 (1994) 1111-1120
93. Wieacker P., Missbach D., Jakubiczka S., Borgmann S., and Albers N. Sex reversal in a child with the karyotype 46, XY, dup (1) (p22.3p32. 3). Clin. Genet. 49 5 (1996) 271-273
94. Yao H.H., Aardema J., and Holthusen K. Sexually dimorphic regulation of inhibin beta B in establishing gonadal vasculature in mice. Biol. Reprod. 74 5 (2006) 978-983
95. Yao H.H., Matzuk M.M., Jorgez C.J., Menke D.B., Page D.C., Swain A., et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev. Dyn. 230 2 (2004) 210-215
96. Yu R.N., Ito M., Saunders T.L., Camper S.A., and Jameson J.L. Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 20 4 (1998) 353-357